| Literature DB >> 16779381 |
Ervina Resetar1, Richard M Reichley, Laura A Noirot, Wm Claiborne Dunagan, Thomas C Bailey.
Abstract
We developed and implemented an adverse drug event system (PharmADE) that detects potentially dangerous drug combinations using a commercial rule base. While commercial rule bases can be useful for rapid deployment of a safety net to screen for drug-drug interactions, they sometimes do not provide the desired rule sensitivity. We implemented methods for enhancing commercial drug-drug interaction rules while preserving the original rule base architecture for easy and low cost maintenance.Mesh:
Year: 2005 PMID: 16779381 PMCID: PMC1560631
Source DB: PubMed Journal: AMIA Annu Symp Proc ISSN: 1559-4076